Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
Completed
Conditions studied: Plexiform Neurofibromas, NF1
In brief
Background: -Plexiform neurofibromas in patients with NF1 are a significant cause of morbidity but little is known about the natural history of these lesions. Objectives: * The purpose of this study is to monitor the natural history of plexiform neurofibromas and to evaluate the usefulness of volumetric MRI tumor measurements in this disease. * Other goals of the study are to provide a body of normative data on the growth rate of plexiform neurofibromas and to establish a tissue repository and pathology review center to allow future studies of the pathogenesis of neurofibromas and clinical trials of potential therapeutic agents. Design \- This study is coordinated by Dr. Bruce Korf, and was initiated when he was at the Partners Center for Human Genetics, Boston, MA.
Key facts
- Study ID
- NCT00006435
- Run by
- National Cancer Institute (NCI)
- People needed
- 24
- Starts
- 2001-05-18
- Expected to finish
- 2020-05-01
- Last updated by the study team
- 2020-05-04
Who can join
Age: any, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.